Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden
Schönning, A. ; Karlén, J. ; Frisk, T ; Heyman, M M ; Svahn, J. E. LU ; Øra, I. LU
; Kawan, L.
; Holmqvist, B. M.
; Björklund, C.
and Harila-Saari, Arja
, et al.
(2017)
In Thrombosis Research
152.
p.64-68
- Abstract
Introduction Pediatric patients with Hodgkin lymphoma (HL) have several risk factors for venous thromboembolism (VTE). Although these patients are occasionally treated with thromboprophylaxis, no guidelines are implemented in Sweden. Scarce data from adult patients indicate an increased risk of VTE, but pediatric data is largely missing. Given the favorable overall survival of HL, there should reasonably be more focus on preventing complications. Materials and methods We conducted a retrospective cohort study, including all patients registered in the Childhood Cancer Registry under the age of 18 years diagnosed with HL between January 2005 and December 2015 in Sweden. Results Data was retrieved from the medical records of all 163... (More)
Introduction Pediatric patients with Hodgkin lymphoma (HL) have several risk factors for venous thromboembolism (VTE). Although these patients are occasionally treated with thromboprophylaxis, no guidelines are implemented in Sweden. Scarce data from adult patients indicate an increased risk of VTE, but pediatric data is largely missing. Given the favorable overall survival of HL, there should reasonably be more focus on preventing complications. Materials and methods We conducted a retrospective cohort study, including all patients registered in the Childhood Cancer Registry under the age of 18 years diagnosed with HL between January 2005 and December 2015 in Sweden. Results Data was retrieved from the medical records of all 163 patients (100%) at six Swedish pediatric cancer centers. The incidence of VTE was 7.7% (symptomatic VTE 3.9%). The median follow-up was 3.4 years (range 0.3–10.5). Only five patients (3.1%) were treated with thromboprophylaxis. All VTE events occurred in the older age category (11–17 years) and all but one (92.7%) had a mediastinal mass. While the VTE did not significantly affect the treatment of HL, it caused increased morbidity and 2/12 developed a post-thrombotic syndrome. No significant risk factors for VTE were identified. Conclusions VTE is a relatively common complication of HL and its treatment, causing increased acute and long-term morbidity. However, due to limited number of events we could not demonstrate risk-factors for VTE that would identify patients who might benefit from thromboprophylaxis.
(Less)
- author
- Schönning, A.
; Karlén, J.
; Frisk, T
; Heyman, M M
; Svahn, J. E.
LU
; Øra, I.
LU
; Kawan, L.
; Holmqvist, B. M.
; Björklund, C.
and Harila-Saari, Arja
, et al. (More)
- Schönning, A.
; Karlén, J.
; Frisk, T
; Heyman, M M
; Svahn, J. E.
LU
; Øra, I.
LU
; Kawan, L.
; Holmqvist, B. M.
; Björklund, C.
; Harila-Saari, Arja
and Ranta, S
(Less)
- organization
- publishing date
- 2017-04-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Adolescents, Children, Hodgkin lymphoma, Venous thromboembolism
- in
- Thrombosis Research
- volume
- 152
- pages
- 5 pages
- publisher
- Elsevier
- external identifiers
-
- pmid:28249199
- wos:000399245600013
- scopus:85013821421
- ISSN
- 0049-3848
- DOI
- 10.1016/j.thromres.2017.02.011
- language
- English
- LU publication?
- yes
- id
- 2578ad64-f227-4a12-a402-a80ea3c754f5
- date added to LUP
- 2017-03-09 12:17:21
- date last changed
- 2025-03-18 20:08:36
@article{2578ad64-f227-4a12-a402-a80ea3c754f5,
abstract = {{<p>Introduction Pediatric patients with Hodgkin lymphoma (HL) have several risk factors for venous thromboembolism (VTE). Although these patients are occasionally treated with thromboprophylaxis, no guidelines are implemented in Sweden. Scarce data from adult patients indicate an increased risk of VTE, but pediatric data is largely missing. Given the favorable overall survival of HL, there should reasonably be more focus on preventing complications. Materials and methods We conducted a retrospective cohort study, including all patients registered in the Childhood Cancer Registry under the age of 18 years diagnosed with HL between January 2005 and December 2015 in Sweden. Results Data was retrieved from the medical records of all 163 patients (100%) at six Swedish pediatric cancer centers. The incidence of VTE was 7.7% (symptomatic VTE 3.9%). The median follow-up was 3.4 years (range 0.3–10.5). Only five patients (3.1%) were treated with thromboprophylaxis. All VTE events occurred in the older age category (11–17 years) and all but one (92.7%) had a mediastinal mass. While the VTE did not significantly affect the treatment of HL, it caused increased morbidity and 2/12 developed a post-thrombotic syndrome. No significant risk factors for VTE were identified. Conclusions VTE is a relatively common complication of HL and its treatment, causing increased acute and long-term morbidity. However, due to limited number of events we could not demonstrate risk-factors for VTE that would identify patients who might benefit from thromboprophylaxis.</p>}},
author = {{Schönning, A. and Karlén, J. and Frisk, T and Heyman, M M and Svahn, J. E. and Øra, I. and Kawan, L. and Holmqvist, B. M. and Björklund, C. and Harila-Saari, Arja and Ranta, S}},
issn = {{0049-3848}},
keywords = {{Adolescents; Children; Hodgkin lymphoma; Venous thromboembolism}},
language = {{eng}},
month = {{04}},
pages = {{64--68}},
publisher = {{Elsevier}},
series = {{Thrombosis Research}},
title = {{Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden}},
url = {{http://dx.doi.org/10.1016/j.thromres.2017.02.011}},
doi = {{10.1016/j.thromres.2017.02.011}},
volume = {{152}},
year = {{2017}},
}